The Affordable Insulin Now Act (hr6833-117) would cap cost-sharing for insulin products at $35 monthly under private insurance and Medicare, directly regulating the Pharmaceuticals & Biotech industry. Rep. Angie Craig (D-MN) is the bill's primary sponsor. Pharmaceuticals & Biotech represents 2.8% of Craig's identifiable donor base ($0.47M), ranking 47th among 252 donor industries within her party.

FOLLOW THE TRAIL
◈ Ask the Analyst about Angie Craig →How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated July 6, 2026 · internal signal score 47/100.